MGE Energy에 대한 매도 수량은 투자자에게 MGE Energy의 주식 하락에 베팅하는 정도를 알려줍니다. 매도 수량 데이터는 2주마다 업데이트됩니다.

MGE Energy (NASDAQ:MGEE) 주식, 공매도 수량 보고

MGE Energy

MGE Energy Inc is a U.S. public utilities holding company based in Wisconsin. The firm generates, purchases, and distributes electricity and natural gas, and also provides transmission services, the company generates electricity from coal and purchased power, but also from natural gas, fuel oil, and renewable sources. MGE operates through five segments, which include Regulated electric utility operations, Regulated gas utility operations, Non-regulated energy operations, Transmission investments, and All other segments which include investing in companies and property and financing the regulated operations. The majority of electric retail revenue is derived from commercial consumers whereas the majority of natural gas revenue is derived from residential consumers.

MGE Energy Inc

Morgan Stanley analyst Stephen Byrd maintains MGE Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGEE#NASDAQ">MGEE</a>) with a Underweight and raises the price target from $71 to $74.

News

Price Target

Analyst Ratings

MGEE

Morgan Stanley Maintains Underweight on MGE Energy, Raises Price Target to $74

Morgan Stanley analyst Stephen Byrd maintains MGE Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGEE#NASDAQ">MGEE</a>) with a Underweight and raises the price target from $66 to $71.

Morgan Stanley Maintains Underweight on MGE Energy, Raises Price Target to $71

Payable Sept. 15, 2024, To Shareholders Of Record On Sept. 1, 2024.

Dividends

MGE Energy Board Of Directors Increases Quarterly Dividend Rate By 5.3% To $0.45 Per Share, Raising Annualized Rate To $1.80 Per Share

MGE (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mgee#NASDAQ">MGEE</a>) came out with quarterly earnings of $0.66 per share, missing the Zacks Consensus Estimate of $0.95 per share. This compares to earnings of $0.79 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of -30.53%. A quarter ago, it was expected that this public utility holding company would post earnings of $0.94 per share when it actually produced earnings of $0.93, delivering a surprise of -1.06%.
Over the last four quarters, the company has not been able to surpass consensus EPS estimates.
MGE, which belongs to the Zacks Utility - Electric Power industry, posted revenues of $145.71 million for the quarter ended June 2024, missing the Zacks Consensus Estimate by 3.69%. This compares to year-ago revenues of $148 million. The company has not been able to beat consensus revenue estimates over the last four quarters.
The sustainability of the stock&#39;s immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management&#39;s commentary on the earnings call.
MGE shares have added about 18% since the beginning of the year versus the S&amp;P 500&#39;s gain of 9.9%.
<h2>What&#39;s Next for MGE?</h2>
While MGE has outperformed the market so far this year, the question that comes to investors&#39; minds is: what&#39;s next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company&#39;s earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for MGE: mixed. While the magnitude and direction of estimate revisions could change following the company&#39;s just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future.
It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is $1.17 on $163.82 million in revenues for the coming quarter and $3.69 on $674.38 million in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Utility - Electric Power is currently in the top 37% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Another stock from the same industry, Vistra Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vst#NYSE">VST</a>), has yet to report results for the quarter ended June 2024. The results are expected to be released on August 8.
This company is expected to post quarterly earnings of $1.59 per share in its upcoming report, which represents a year-over-year change of +54.4%. The consensus EPS estimate for the quarter has been revised 5% lower over the last 30 days to the current level.
Vistra Corp.&#39;s revenues are expected to be $4.04 billion, up 26.7% from the year-ago quarter.
<a href="https://www.zacks.com/stock/news/2318331/mge-mgee-misses-q2-earnings-and-revenue-estimates?cid=CS-BENZ-FT-tale_of_the_tape|yseop_template_4-2318331">To read this article on Zacks.com click here.</a>

Earnings

Earnings Misses

Markets

Trading Ideas

MGE Misses Q2 Earnings and Revenue Estimates

Morgan Stanley analyst Stephen Byrd maintains MGE Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGEE#NASDAQ">MGEE</a>) with a Underweight and lowers the price target from $68 to $65.

Morgan Stanley Maintains Underweight on MGE Energy, Lowers Price Target to $65

Morgan Stanley analyst Stephen Byrd maintains MGE Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGEE#NASDAQ">MGEE</a>) with a Underweight and raises the price target from $63 to $68.

Morgan Stanley Maintains Underweight on MGE Energy, Raises Price Target to $68

MGE Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGEE#NASDAQ">MGEE</a>) reported quarterly earnings of $0.93 per share. The company reported $191.34 million in sales this quarter. This is a 11.93 percent decrease over sales of $217.25 million the same period last year.

MGE Energy Q1 2024 GAAP EPS $0.93, Sales $191.34M Down From $217.25M YoY

Shares of Bitdeer Technologies Group (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/btdr#NASDAQ">BTDR</a>) rose sharply during Monday&rsquo;s session after the company reported preliminary fourth-quarter financial results, announced the successful testing of its SEAL01 Bitcoin mining chip and amid overall strength in the price of Bitcoin.
Bitdeer Technologies Group shares jumped 10.2% to $7.45 on Monday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>BitFuFu Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fufu#NASDAQ">FUFU</a>) shares jumped 107% to $13.20 amid volatility following the company&#39;s recent business combination with Arisz Acquisition Corp and listing on the Nasdaq.</li>
<li>Quoin Pharmaceuticals, Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qnrx#NASDAQ">QNRX</a>) climbed 89% to $5.31 after the company announced FDA clearance to recruit teen subjects into both of its ongoing Netherton Syndrome clinical studies.</li>
<li>Renalytix Plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rnlx#NASDAQ">RNLX</a>) gained 52.8% to $1.5890 after the company announced that it received an unsolicited approach from a publicly listed strategic diagnostics company.</li>
<li>Phunware, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/phun#NASDAQ">PHUN</a>) climbed 42.7% to $10.11. Phunware is expected to report fourth-quarter results on March 12, 2024.</li>
<li>Ainos, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aimd#NASDAQ">AIMD</a>) gained 39.4% to $1.4650.</li>
<li>Jaguar Health, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jagx#NASDAQ">JAGX</a>) shares climbed 38.2% to $0.1223 after surging 50% on Friday.</li>
<li>Cardiff Oncology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crdf#NASDAQ">CRDF</a>) rose 31.6% to $3.83 after the company reported better-than-expected fourth-quarter financial results, provided a clinical update on the Phase 2 randomized second-line ONSEMBLE trial in patients with RAS-mutated mCRC and announced the first patient was dosed in the randomized first-line RAS-mutated mCRC trial.</li>
<li>The E.W. Scripps Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ssp#NASDAQ">SSP</a>) gained 31.3% to $4.94. E.W. Scripps Director Charles L. Barmonde acquired a total of 10,500 shares an average price of $4.28.</li>
<li>Helius Medical Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hsdt#NASDAQ">HSDT</a>) climbed 30% to $5.91. Helius Medical Technologies announced it secured HCPCS codes for portable neuromodulation stimulator mouthpiece and controller.</li>
<li>Kineta, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ka#NASDAQ">KA</a>) gained 27% to $1.14. Kineta recently announced a restructuring and the exploration of strategic alternatives.</li>
<li>BigBear.ai Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bbai#NYSE">BBAI</a>) rose 25% to $4.3472.</li>
<li>Critical Metals Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crml#NASDAQ">CRML</a>) gained 24.4% to $12.44.</li>
<li>Ocean Biomedical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ocea#NASDAQ">OCEA</a>) gained 22% to $2.44.</li>
<li>Reliance Global Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/reli#NASDAQ">RELI</a>) rose 21.7% to $0.6299 after gaining 11% on Friday.</li>
<li>Akero Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/akro#NASDAQ">AKRO</a>) climbed 21.1% to $33.69 after gaining 3% on Friday.</li>
<li>89bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/etnb#NASDAQ">ETNB</a>) gained 20.3% to $15.18.</li>
<li>Nektar Therapeutics (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nktr#NASDAQ">NKTR</a>) gained 19.4% to $0.9315. Nektar Therapeutics announced a $30 million private placement financing with TCGX.</li>
<li>Super Micro Computer, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smci#NASDAQ">SMCI</a>) shares gained 18.9% to $1,076.45. Super Micro Computer will join the S&amp;P 500 Index, effective March 18, S&amp;P Dow Jones Indices, a division of S&amp;P Global, said in a release.</li>
<li>MicroStrategy Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mstr#NASDAQ">MSTR</a>) gained 17.8% to $1,271.51 amid strength in Bitcoin.</li>
<li>Macy&#39;s, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/m#NYSE">M</a>) rose 16.3% to $20.95 after Arkhouse and Brigade Capital increased their offer to acquire Macy&#39;s to $24 per share.</li>
<li>Renovaro Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/renb#NASDAQ">RENB</a>) gained 14.3% to $2.64.</li>
<li>Digital World Acquisition Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dwac#NASDAQ">DWAC</a>) gained 13.4% to $44.18 after falling over 5% on Friday.</li>
<li>MGE Energy, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mgee#NASDAQ">MGEE</a>) rose 12% to $70.75. MGE Energy will replace iRobot in the S&amp;P SmallCap 600.</li>
<li>BGC Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bgc#NASDAQ">BGC</a>) gained 11.8% to $7.93. BGC Group is set to join S&amp;P SmallCap 600.</li>
<li>Jin Medical International Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zjyl#NASDAQ">ZJYL</a>) climbed 11.6% to $7.10.</li>
<li>H&amp;R Block, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hrb#NYSE">HRB</a>) gained 8.9% to $52.08.</li>
<li>Aadi Bioscience, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aadi#NASDAQ">AADI</a>) shares surged 8.8% to $2.0899 after the company announced publication of long-term efficacy and safety data further supporting FYARRO&reg; for the treatment of malignant PEComa.</li>
<li>MSP Recovery, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lifw#NASDAQ">LIFW</a>) shares rose 7.7% to $1.11. LifeWallet announced a comprehensive settlement with 28 affiliated property and casualty insurers, benefiting LifeWallet&rsquo;s <a href="https://www.benzinga.com/money/best-medicare-advantage-plans/">medicare</a> clients across the U.S.</li>
<li>Coinbase Global, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/coin#NASDAQ">COIN</a>) climbed 7.5% to $221.11 amid a rise in the price of Bitcoin.</li>
<li>Box, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/box#NYSE">BOX</a>) gained 6.6% to $28.30. Box will replace Forrester Research Inc in the S&amp;P SmallCap 600.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>BioVie Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bivi#NASDAQ">BIVI</a>) fell 42.7% to $1.0830 after the company reported pricing of public offering.</li>
<li>JOANN Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/joan#NASDAQ">JOAN</a>) fell 38.7% to $ .3102&nbsp;following a report suggesting the company may file for bankruptcy soon.</li>
<li>Astra Space, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/astr#NASDAQ">ASTR</a>) dipped 35% to $0.8598.</li>
<li>BioCardia, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bcda#NASDAQ">BCDA</a>) fell 23.3% to $0.4449 after reporting interim results from Phase III CardiAMP cell therapy heart failure trial.</li>
<li>MMTec, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mtc#NASDAQ">MTC</a>) declined 21.8% to $2.00.</li>
<li>Vivani Medical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vani#NASDAQ">VANI</a>) declined 21.7% to $2.4199. Vivani Medical recently announced the pricing of a $15 million registered direct offering of common stock and warrants.</li>
<li>Interactive Strength Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/trnr#NASDAQ">TRNR</a>) tumbled 19.8% to $0.40. Interactive Strength recently announced it has entered into an exclusive worldwide distribution agreement with WOODWAY to sell and distribute CLMBR.</li>
<li>Infobird Co., Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ifbd#NASDAQ">IFBD</a>) dipped 19.3% to $5.03</li>
<li>Minim, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/minm#NASDAQ">MINM</a>) fell 18.4% to $4.7395 after jumping 35% on Friday.</li>
<li>Avidity Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rna#NASDAQ">RNA</a>) fell 16.6% to $16.78. Avidity Biosciences announced new long-term AOC 1001 data from the Marina-OLE trial showing reversal of disease progression in Myotonic Dystrophy Type 1 patients across multiple endpoints.</li>
<li>Playtika Holding Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pltk#NASDAQ">PLTK</a>) fell 14.8% to $6.44</li>
<li>Aptevo Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apvo#NASDAQ">APVO</a>) declined 14.7% to $0.1399.</li>
<li>J-Long Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jl#NASDAQ">JL</a>) shares dipped 14.3% to $1.98 after jumping over 15% on Friday. J-Long Group recently declared a special cash dividend in aggregate amount of $6 million.</li>
<li>Sunshine Biopharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sbfm#NASDAQ">SBFM</a>) fell 14.3% to $0.0474. Sunshine Biopharma, last month, announced closing of $10.0 million underwritten public offering.</li>
<li>New York Community Bancorp, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nycb#NASDAQ">NYCB</a>) fell 13.6% to $3.0650 after the company announced that it identified material weaknesses in its internal controls related to internal loan review, that resulted from ineffective oversight, risk assessment and monitoring activities.</li>
<li>Spirit Airlines, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/save#NYSE">SAVE</a>) fell 12.1% to $5.68 after the company announced the termination of its merger agreement with JetBlue.</li>
<li>Sabre Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sabr#NASDAQ">SABR</a>) fell 11.6% to $2.3050. Sabre announced exchange of $150 million of existing 4.000% exchangeable senior notes due 2025 for exchangeable senior notes due 2026.</li>
<li>Li Auto Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/li#NASDAQ">LI</a>) fell 11.6% to $38.49. B of A Securities analyst Ming Hsun Lee maintained Li Auto with a Buy and raised the price target from $57 to $60.</li>
<li>Revance Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rvnc#NASDAQ">RVNC</a>) fell 11.2% to $6.20. Revance announced pricing of $100 million public offering of 16 million shares of common stock at a price of $6.25 per share.</li>
<li>Beyond Meat, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bynd#NASDAQ">BYND</a>) dipped 11.3% to $8.67 after the company announced that it was unable to file its annual report due to technical difficulties in assembling the submission for filing. Also, the company said it anticipates it will seek to raise additional capital in 2024.</li>
<li>Caledonia Mining Corporation Plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmcl#NASDAQ">CMCL</a>) shares tumbled 9.6% to $9.29 after the company issued a trading update for the year ended Dec. 31, 2023.</li>
<li>Hertz Global Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/htz#NYSE">HTZ</a>) fell 7.2% to $7.26.</li>
<li>NIO Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nio#NYSE">NIO</a>) fell 6.9% to $5.38.</li>
</ul>
&nbsp;
Now Read This: <a href="	https://www.benzinga.com/trading-ideas/long-ideas/24/03/37454953/charles-colvard-and-3-other-penny-stocks-insiders-are-buying"> Charles &amp; Colvard And 3 Other Penny Stocks Insiders Are Buying </a>

Penny Stocks

Small Cap

Intraday Update

Movers

AADI

AIMD

AKRO

APVO

ASTR

BBAI

BCDA

BIVI

BTDR

BYND

CMCL

COIN

CRDF

CRML

DWAC

ETNB

FUFU

HSDT

IFBD

JAGX

JOAN

LIFW

MINM

MSTR

NKTR

NYCB

OCEA

PHUN

PLTK

QNRX

RELI

RENB

RNLX

RVNC

SABR

SAVE

SBFM

SMCI

TRNR

VANI

ZJYL

Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session

WIIM

MGE Energy shares are trading higher after it was announced the company will join the S&P SmallCap 600.

MGE Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGEE#NASDAQ">MGEE</a>) reported quarterly earnings of $0.55 per share. The company reported $164.65 million in sales this quarter. This is a 13.26 percent decrease over sales of $189.83 million the same period last year.

MGE Energy Q4 2023 GAAP EPS $0.55, Sales $164.65M Down From $189.83M YoY

Morgan Stanley analyst Stephen Byrd maintains MGE Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGEE#NASDAQ">MGEE</a>) with a Underweight and raises the price target from $61 to $62.

Morgan Stanley Maintains Underweight on MGE Energy, Raises Price Target to $62

Morgan Stanley analyst Stephen Byrd maintains MGE Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGEE#NASDAQ">MGEE</a>) with a Underweight and lowers the price target from $65 to $61.

Morgan Stanley Maintains Underweight on MGE Energy, Lowers Price Target to $61

Morgan Stanley analyst Stephen Byrd maintains MGE Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGEE#NASDAQ">MGEE</a>) with a Underweight and raises the price target from $63 to $65.

Morgan Stanley Maintains Underweight on MGE Energy, Raises Price Target to $65

Wednesday marks the last chance for investors to receive the next dividend payout from MGE Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGEE#NASDAQ">MGEE</a>). 
<h3>What's Happening</h3>
The company announced on Friday that it would pay shareholders a quarterly dividend of 42.75 cents per share. On Thursday, MGE Energy will go ex-dividend, meaning the stock will trade lower to reflect that payout. In other words, the stock will likely open 42.75 cents lower than it would have opened on any other day.
In order to be eligible to receive a company's dividend, shareholders must own the stock prior to the ex-dividend date—in this case, Thursday. Shareholders who own MGEE as of the end of Wednesday's session are eligible to receive the 42.75 cents dividend payout for every share that they own. 
According to the company, this dividend will be paid out to shareholders on September 15, 2023. Investors will then be able to either reinvest those dividends back into the stock or use the payment in some other way. 
<a href="https://www.benzinga.com/quote/MGEE">Track real-time stock fluctuations for MGE Energy on Benzinga.</a>

MGE Energy's Ex-Dividend Date Is Thursday, Here's What You Need To Know

Morgan Stanley analyst Stephen Byrd maintains MGE Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGEE#NASDAQ">MGEE</a>) with a Underweight and lowers the price target from $67 to $63.

Morgan Stanley Maintains Underweight on MGE Energy, Lowers Price Target to $63

August 18, 2023&mdash;The board of directors of MGE Energy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGEE#NASDAQ">MGEE</a>), today increased the regular quarterly dividend rate approximately 5% to $0.4275 per share on the outstanding shares of the company&#39;s common stock. The dividend is payable Sept. 15, 2023, to shareholders of record Sept. 1, 2023. This raises the annualized dividend rate by 8 cents from $1.63 per share to $1.71 per share.
&quot;We continue to move forward in our clean energy transition to provide our customers safe, reliable and affordable clean energy. Today&#39;s action by our board demonstrates the continued strength and resilience of MGE Energy&#39;s long-term business strategy in building your community energy company for the future,&quot; said Chairman, President and CEO Jeff Keebler. &quot;For nearly half a century, our board has taken action to increase the dividend and to reinforce the importance of dividend growth to the overall shareholder value proposition by providing regular, predictable, sustainable dividends.&quot;
MGE Energy has increased its dividend annually for the past 48 years and has paid cash dividends for more than 110 years.

MGE Energy Increases Quarterly Dividend From $0.4075 To $0.4275/Share

MGE Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGEE#NASDAQ">MGEE</a>) reported quarterly earnings of $0.79 per share which beat the analyst consensus estimate of $0.69 by 14.49 percent. This is a 31.67 percent increase over earnings of $0.60 per share from the same period last year. The company reported quarterly sales of $148.00 million which beat the analyst consensus estimate of $144.42 million by 2.48 percent. This is a 2.86 percent decrease over sales of $152.35 million the same period last year.

Earnings Beats

MGE Energy Q2 EPS $0.79 Beats $0.69 Estimate, Sales $148.00M Beat $144.42M Estimate

Morgan Stanley analyst Stephen Byrd maintains MGE Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGEE#NASDAQ">MGEE</a>) with a Underweight and lowers the price target from $68 to $67.

Morgan Stanley Maintains Underweight on MGE Energy, Lowers Price Target to $67

Morgan Stanley analyst Stephen Byrd maintains MGE Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGEE#NASDAQ">MGEE</a>) with a Underweight and lowers the price target from $70 to $68.

Morgan Stanley Maintains Underweight on MGE Energy, Lowers Price Target to $68

Over the past 3 months, 4 analysts have published their opinion on MGE Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGEE#NASDAQ">MGEE</a>) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
According to 4 analyst offering 12-month price targets in the last 3 months, MGE Energy has an average price target of $70.5 with a high of $72.00 and a low of $68.00. 
Below is a summary of how these 4 analysts rated MGE Energy over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and the greater the number of bearish ratings, the more negative analysts are on the stock
<img src="https://www.benzinga.com/files/images/story/2023/1684767696_0.png" alt="price target chart" />
This current average has increased by 0.71% from the previous average price target of $70.00. 
<a href="https://www.benzinga.com/quote/MGEE/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on MGE Energy analyst ratings.</a>
<h1>Analyst Ratings: What Are They?</h1>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

The Latest Analyst Ratings for MGE Energy

MGE Energy: Buy This Dividend Champion While It's On Sale

MGE Energy raises dividend by 5.3% to $0.45

14 Upcoming Dividend Increases Including 2 Kings

Morgan Stanley analyst David Arcaro maintained a Sell rating on MGE Energy (MGEE – Research Report) today and set a price target of $71.00. The com...

Morgan Stanley Remains a Sell on MGE Energy (MGEE)

Dividend Champion, Contender, And Challenger Highlights: Week Of August 25

Microsoft, McDonald's Among 13 Companies To Reward Investors With Increased Dividends In September

Dividend Champion, Contender, And Challenger Highlights: Week Of September 8

In a report released today, David Arcaro from Morgan Stanley maintained a Sell rating on MGE Energy (MGEE – Research Report), with a price target o...

Comments

MGE Energy

매도 수량

MGE Energy (NASDAQ:MGEE) 주식, 공매도 수량 보고

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌